Recently, we have shown that the TRD patients, who later received ketamine in vitro and were mostly included in this study, had higher serum IL-8 than healthy people—serum IL-8 levels above 19.55 pg/mL were associated with a 10.26 likelihood ratio of developing TRD [18]. This evidence concerns the gene CXCL8 and treatment resistant depression.